ABSTRACT Direct effects of adrenergic stimuli on coronary vessels in dogs were compared with effects on vessels to skin (hind paw) and skeletal muscle (gracilis muscle) after intravenous administration of practolol (2 mg/kg), a selective myocardial beta receptor blocker which minimized indirect effects of myocardial stimulation on coronary vascular resistance. The left circumflex coronary, cranial tibial, and gracilis arteries were perfused separately but simultaneously at constant flow.
In contrast to norepinephrine, the predominant direct effect of epinephrine on coronary vessels was dilatation mediated through activation of vascular beta receptors. A constrictor effect caused by stimulation of alpha receptors was unmasked by propranolol.
Finally, the order of potency of agonists in stimulating coronary vascular beta receptors and the demonstration of selective beta receptor blockade with practolol suggest that beta receptors in coronary vessels resemble those in peripheral vessels more than those in myocardium.
INTRODUCTION
Several investigators have reported studies of coronary vascular responses to adrenergic stimuli (2-10), but until recently it has been difficult in the intact beating heart to separate the direct effects of these stimuli on coronary vessels from indirect effects resulting from stimulation of the myocardium. Consequently, there is little available information comparing direct effects of adrenergic stimuli on coronary vessels with effects on vessels in other vascular beds. Recently we studied coronary vascular responses to adrenergic stimuli in the intact beating heart using practolol (11) , a new agent which in low doses blocks myocardial but not vascular beta receptors (12) . These studies indicated that the coronary vasodilator action of sympathetic nerve stimulation and norepinephrine was indirect and caused by activation of beta receptors in the myocardium. The direct effect of nerve stimulation and norepinephrine on coronary vessels was constriction, but the constrictor responses seemed small compared to those reported with the same stimuli in other vascular beds.
The present experiments were done to compare the direct effects of adrenergic stimuli on coronary vessels with effects on vessels to skin and skeletal muscle, and to identify the mechanisms for differences in coronary responses and responses in skin and skeletal muscle.
The Journal of Clinical Investigation Volume 51 1972 thoracotomy, the pericardium was incised and a short segment of the left circumflex coronary artery near its origin was exposed. The cranial tibial artery to the hind paw was exposed near the tarsus and collateral arteries at this level were ligated. In the same hind limb, the gracilis muscle was dissected free from all of its vascular connections with the exception of the gracilis artery and vein. The coronary, tibial, and gracilis arteries then were cannulated and perfused at constant flow with heparinized blood from the femoral artery using perfusion pumps. The cannula from the femoral artery was trifurcated upstream from the pumps to permit separate and simultaneous perfusion of the three arteries. Flows ranged from 48 to 56 ml/min to the coronary artery, 24 to 32 ml/min to the hind paw, and 14 to 17 ml/min to the gracilis muscle. These flows yielded perfusion pressures in the same range as systemic arterial pressure before denervation. With flow constant, changes in perfusion pressure to each bed reflected changes in vascular resistance for that vascular bed. Responses to stimuli were taken as peak changes in perfusion pressure. Perfusion pressures fell abruptly to 10-20 mm Hg when the pumps were stopped and there was essentially no back flow of blood from the distal end of the partially transected vessels suggesting that there was little or no collateral flow. In addition to perfusion pressures, we measured aortic and left ventricular pressures, left ventricular dP/dt (LV' dP/ dt), and heart rate. LV dP/dt was obtained using a No. 7F cardiac catheter, a Statham P23Db pressure transducer,2 and an RC differentiating circuit with a time constant of 0.5 msec. Beat to beat changes in heart rate were measured using a cardiotachometer.
Drugs used as agonists were 1-norepinephrine bitartrate, phenylephrine hydrochloride, val'-angiotensin-11 amide, isoproterenol hydrochloride, glyceryl trinitrate, and epinephrine hydrochloride. Doses of norepinephrine are expressed in terms of base. Fresh solutions were prepared for each experiment using appropriate dilutions of stock solutions in 5% dextrose in water. The agonists were injected into the perfusion tubing before it trifurcated upstream from the pump so that equal concentrations reached each perfused 'Abbreviations used in this paper: LV, left ventricular. 2 Statham Instruments, Inc., Los Angeles, Calif.
bed. The drugs were injected in volumes of 0.1-0.2 ml; inj ections of these volumes of dextrose solution alone had no effect. Other drugs used in the study were practolol3 and propranolol, which were given intravenously, and phentolamine, which was administered into the perfusion tubing.
Direct electrical nerve stimulation was accomplished by stimulating the regional sympathetic nerves to each bed separately and consecutively at supramaximal voltage with pulses of 4 msec at variable frequency for 30 sec. The left cardiac nerves were sectioned close to the left stellate ganglion and stimulated to obtain coronary responses. The distal ends of the cut sciatic and obturator nerves were stimulated to obtain responses in the hind paw and gracilis muscle, respectively. Supramaximal voltage, which was determined for each nerve in each experiment, was usually 10 v for the cardiac nerves, 15-20 v for the obturator nerve and 20-25 v for the sciatic nerve.
In the first series of experiments these methods were used to compare responses of the three beds to nerve stimulation, phenylephrine, angiotensin, and isoproterenol after intravenous administration of practolol, 2 mg/kg, in eight dogs. Angiotensin was administered to determine the reactivity of the coronary vessels to a nonadrenergic constrictor stimulus. Phenylephrine was given to test responses to a relatively pure alpha receptor stimulating agent. Nerve stimulation was performed first followed by administration of the drugs in random order.
In the second series of experiments, we obtained responses to norepinephrine, epinephrine, angiotensin, isoproterenol, and glyceryltrinitrate after practolol, 2 mg/kg intravenously, in 11 dogs. Glyceryltrinitrate was used as an internal dilator control to compare the reactivity of the three beds to dilator stimuli. Norepinephrine, epinephrine, and isoproterenol were administered to determine the relative order of potency of these agonists in stimulating coronary vascular beta receptors. The injections were repeated after propranolol, 0.1 mg/kg intravenously, in seven dogs and after phentolamine, 5 mg given into the perfusion tubing, in three other dogs. Propranolol was given to see if blockade of vascular beta receptors augmented coronary constrictor responses to norepinephrine. Phentolamine was administered to see if blockade of the constrictor effect of norepinephrine unmasked a dilator effect. In eight experiments, responses to isoproterenol were obtained after practolol, 1 mg/kg, after another 1 mg/kg dose of practolol, and then after propranolol, 0.2 mg/kg intravenously. This was done to test further the selectivity of beta receptors blockade with practolol. In previous experiments (11) we observed that 1 mg/kg of practolol blocked myocardial and reduced slightly 3Practolol (AY-21,011) was supplied generously by Ayerst Laboratories, New York. coronary responses to isoproterenol. If reduction in the coronary responses after 1 mg/kg of practolol resulted from partial blockade of coronary vascular beta receptors, rather than from inhibition of the indirect dilator responses caused by myocardial stimulation, then another 1 mg/kg of practolol would be expected to produce additional blockade of coronary vascular beta receptors and further reduction of the dilator responses to isoproterenol.
In the third series of experiments, the catecholamine concentration of the circumflex coronary, cranial tibial, and gracilis arteries from six anesthetized dogs was measured using the improved fluorometric trihydroxyindole method of Higgendal (13) . Segments of the gracilis artery in both hind limbs were excised and pooled as were segments of the cranial tibial artery. The heart was removed and segments of the circumflex coronary and its branches were excised rapidly and pooled. The arteries were quickly stripped of loose connective tissue, blotted, weighed, and frozen in liquid nitrogen. The frozen vessels were pulverized in a stainless steel apparatus which had been cooled to the temperature of liquid nitrogen. The crushed frozen tissue was transferred to an ice-cold Potter-Elvehjem grinding tube and homogenized for 1 min in 0.4 N perchloric acid.
Following centrifugation (9000 g) at 0C for 15 min, the precipitate was extracted with 0.4 N HC1O4 and recentrifuged. The supernatants were combined. The catecholamines were extracted by the aluminum-oxide adsorption process of Anton and Sayre (14) . The eluted catecholamines were analyzed using a modification of the trihydroxyindole procedure of Haggendal (13) . Faded tissue blanks and a series of standards were routinely analyzed with each sample.
Standards were prepared from pure 1-norepinephrine HCl.4 Fluorescence was measured in a Perkin-Elmer MPF-2A spectrophotometer5 equipped with a high sensitivity cell holder. Linear curves were obtained with standards ranging 4Sigma Chemical Co., St. Louis, Mo. 'Perkin-Elmer Corp., Boller & Chivens Div., South Pasadena, Calif. from 0 to 50 ng of norepinephrine. At high sensitivity settings 10 ng of norepinephrine gave full scale readings. The data has not been corrected for losses in the purification procedures.
Statistical comparisons were performed using the t test for paired data.
RESULTS
Effects of practolol on base line observations (Table  I, Figs. 1 and 2 ). Coronary and gracilis perfusion pressures increased after intravenous administration of practolol while heart rate and left ventricular pressure and dP/dt decreased. Perfusion pressure in the paw increased slightly, but not significantly, after practolol.
Responses after practolol (Tables II and III, Figs.  1-3) . Nerve stimulation, norepinephrine and phenylephrine resulted in small increases in coronary perfusion pressure compared with large increases in perfusion pressure in the paw and gracilis muscle. In contrast, angiotensin produced large coronary constrictor responses which were greater than the responses in the paw and only slightly less than those in the gracilis muscle. Epinephrine produced coronary dilatation, but caused vasoconstriction in the paw and gracilis muscle which resembled that seen with norepinephrine and 'In six fluorometric determinations the average recovery of norepinephrine from the alumina extraction process was 76.3 ±3.6% (SEM). In one additional determination using tritiated norepinephrine (1-NE-7-Ha) 93.2% of the label was adsorbed by the alumina. Successive washes of the alumina removed increasing amounts of the label, up to 6.3% with the fourth wash. Recovery of 1-NE-7-H' in the alumina extract was 73.1 %. pressure and dP/dt, with the exception of increases in dP/dt and pressure with the high dose of norepinephrine and smaller but significant increases in dP/dt with the high dose of isoproterenol and angiotensin (P < 0.05, Table III ).
Effects of propranolol after practolol (Table IV) . were not reduced. The concentration in cranial tibial and coronary vessels Effects of phentolamnine after practolol (Table V) . did not differ significantly (P >0.05), but the concenPhentolamine reduced, but did not reverse, constrictor tration of both exceeded that in the gracilis arteries responses to norepinephrine. Constrictor responses to (P <0.05). (15) , on coronary vessels was minimal compared with effects on cutaneous and muscular vessels, it is unlikely that differences in constrictor effects of adrenergic stimuli on the three beds result from differences in uptake into nerve endings. We conclude, therefore, that the differences in the direct constrictor effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels result from a paucity of alpha receptors in coronary vessels compared with vessels in the other two beds.
Direct dilator responses to the beta receptor stimulating agent, isoproterenol, in the coronary circulation approximated those in the paw, but were less than those in the gracilis muscle. It is difficult to draw conclusions concerning the relative density of beta receptors in the three vascular beds from these observations, because responses to glyceryl trinitrate, used as an internal dilator control, also were larger in the gracilis muscle than in the paw and coronary. Differences in effects of isoproterenol may reflect differences in reactivity of the three beds to dilator stimuli rather than differences in density of beta receptors.
An unexpected finding in this study was the difference in the direct effects of epinephrine and norepinephrine on coronary vessels. Previous studies in fibrillating or potassium-arrested hearts suggested that the direct coronary effect of both norepinephrine and epinephrine is constriction (4, 5) . In contrast, in studies of isolated strips of coronary vessels from dogs, Zuberbuhler and Bohr found that epinephrine and norepinephrine caused relaxation of strips from small coronary vessels (9) . Norepinephrine was much more potent than epinephrine. On strips from large coronary arteries the two agents produced either relaxation or contraction, with norepinephrine more potent as a dilator and epinephrine more potent as a constrictor (9) . In the present experiments, the direct effect of epinephrine was coronary vasodilatation; the direct effect of norepinephrine was vasoconstriction. Although the dilator responses to epinephrine after practolol occasionally were accompanied by small increases in left ventricular dP/dt, similar responses often occurred without changes in dP/dt, heart rate, and left ventricular pressure (Fig. 3) . In addition, after administration of practolol residual increases in dP/dt with norepinephrine were greater than with epinephrine, but vasodilatation was not seen with norepinephrine.
Administration of propranolol after practolol reversed coronary responses to epinephrine from dilatation to constriction, but did not augment the constriction with norepinephrine. These observations indicate that in these experiments the predominant direct effect of epinephrine on coronary vessels was dilatation mediated through stimulation of vascular beta receptors; a constrictor effect caused by activation of alpha receptors was unmasked by propranolol. The direct effect of norepinephrine was constriction mediated through alpha receptors; vascular beta receptors did not play an important role in responses to norepinephrine.
The catecholamine concentration of coronary arteries exceeded that of gracilis arteries and did not differ significantly from the concentration in cranial tibial arteries, although it tended to be less in coronary vessels. The high concentration in coronary vessels was surprising in view of minimal responsiveness of these vessels to sympathetic nerve stimulation, but the results are consistent with a recent preliminary report by King, Angelakos, and Uzgiris that histochemical techniques reveal dense adrenergic innervation in all coronary vessels (16) reduce the dilator responses produced by the inotropic effects of this agent (24) . We did not observe a significant reduction of the coronary dilator response to isoproterenol after 1 mg/kg of practolol in this study, but did observe a slight reduction in a previous study (11) . We attributed the slight reduction to inhibition of the indirect dilator action resulting from myocardial stimulation and not to blockade of coronary beta receptors. If the latter had occurred, administration of a higher dose of practolol, 2 mg/kg, would have been expected to produce greater blockade of coronary beta receptors and greater reduction of the dilator response to isoproterenol. This was not seen in the present study in which myocardial responses were reduced or abolished by 1 mg/kg of practolol, but coronary responses were not altered by 1 or 2 mg/kg. We conclude from these and other studies (19) (20) (21) that practolol in low doses blocks myocardial but not coronary or peripheral vascular beta receptors. These results, combined with the data on relative potency of agonists in this study, strongly suggest that the beta receptors in coronary vessels resemble those in peripheral vessels more than those in myocardium.
